Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-25-255563
Filing Date
2025-10-29
Accepted
2025-10-29 11:15:09
Documents
16

Document Format Files

Seq Description Document Type Size
1 424B5 d24040d424b5.htm 424B5 639606
2 EX-FILING FEES d24040dexfilingfees.htm   iXBRL EX-FILING FEES 29323
3 GRAPHIC g24040g01a01.jpg GRAPHIC 24020
4 GRAPHIC g24040g01a28.jpg GRAPHIC 30636
5 GRAPHIC g24040g01a52.jpg GRAPHIC 23563
6 GRAPHIC g24040g99a99.jpg GRAPHIC 27021
  Complete submission text file 0001193125-25-255563.txt   948131

Data Files

Seq Description Document Type Size
19 EXTRACTED XBRL INSTANCE DOCUMENT d24040dexfilingfees_htm.xml XML 10543
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-278506 | Film No.: 251428201
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)